The “Normal” FVIII Level Trap in Females with Haemophilia
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, posted on LinkedIn:
”The “Normal” FVIII Level Trap in Females with Haemophilia
For decades, we thought: if factors are normal, the patient is “just a carrier” and shouldn’t bleed. At ASH2025, Dr. Jill Johnsen and the 8CHECK program, with over 500 female,s just shattered that rule with data:
- 52% of genotype-positive females with excessive bleeding had FVIII levels ≥ 40%.
- Normal FVIII levels do NOT exclude excessive bleeding.
What This Means for Clinical Practice:
– FVIII is a poor predictor: High variability makes it an unreliable standalone marker for variant status in females.
– Genotyping is essential: It’s not just for “severe” cases. In this cohort, 62% of tested females had a clinically reportable F8 variant.
– Family History Matters: The yield for finding a variant drops significantly without family history (18.6% vs 67.5%), but positive results still occur.”

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?